Association between hospital volume and receipt of treatment and survival in patients with glioblastoma

Matthew Koshy, David J. Sher, Michael Spiotto, Zain Husain, Herb Engelhard, Konstantin Slavin, Martin K. Nicholas, Ralph R. Weichselbaum, Chad Rusthoven

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The relation between hospital volume and outcomes for patients with glioblastoma is unknown. We undertook this study to determine the effect of hospital volume on treatment received and its effect on survival in patients with glioblastoma. We included patients from the National Cancer Database diagnosed with a glioblastoma from 2006 to 2013. Hospital volume was calculated by examining the treating facilities average number of cases per year and grouping them into tertiles: (low < 9.25, medium 9.26–23.88, and high ≥ 23.39). Treatment was defined as receiving any type of therapeutic surgery, radiation or chemotherapy. Using regression models we examined the relation between hospital volume to treatment received and survival with adjustment for clinical, socioeconomic and institutional factors. The study included 68,726 patients of which 91.8% received treatment. Among patients diagnosed at low volume facilities, 90.1% received treatment versus 94.2% in high volume facilities (p < 0.0001). Compared to low volume centers, the odds ratio of receiving any treatment was 1.01 (CI 95% CI: 0.95–1.09) and 1.43 (95% CI: 1.31–1.55) for medium volume and high volume facilities, respectively. On multivariate analysis for survival among those who received treatment, the hazard of mortality was decreased at high volume (HR 0.92, 95% CI 0.89–0.94) facilities compared to low volume facilities. Patients diagnosed with glioblastoma at a high volume facility (≥23.39 cases per year) have an increased likelihood of receiving treatment. Furthermore, glioblastoma patients may significantly improve their survival by choosing to receive care at a high-volume hospital.

Original languageEnglish (US)
Pages (from-to)529-534
Number of pages6
JournalJournal of Neuro-Oncology
Volume135
Issue number3
DOIs
StatePublished - Dec 1 2017

Fingerprint

Glioblastoma
Survival
Therapeutics
High-Volume Hospitals
Multivariate Analysis
Odds Ratio
Databases
Radiation
Drug Therapy
Mortality

Keywords

  • Brain tumors
  • Glioblastoma
  • Hospital volume

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Association between hospital volume and receipt of treatment and survival in patients with glioblastoma. / Koshy, Matthew; Sher, David J.; Spiotto, Michael; Husain, Zain; Engelhard, Herb; Slavin, Konstantin; Nicholas, Martin K.; Weichselbaum, Ralph R.; Rusthoven, Chad.

In: Journal of Neuro-Oncology, Vol. 135, No. 3, 01.12.2017, p. 529-534.

Research output: Contribution to journalArticle

Koshy, M, Sher, DJ, Spiotto, M, Husain, Z, Engelhard, H, Slavin, K, Nicholas, MK, Weichselbaum, RR & Rusthoven, C 2017, 'Association between hospital volume and receipt of treatment and survival in patients with glioblastoma', Journal of Neuro-Oncology, vol. 135, no. 3, pp. 529-534. https://doi.org/10.1007/s11060-017-2598-2
Koshy, Matthew ; Sher, David J. ; Spiotto, Michael ; Husain, Zain ; Engelhard, Herb ; Slavin, Konstantin ; Nicholas, Martin K. ; Weichselbaum, Ralph R. ; Rusthoven, Chad. / Association between hospital volume and receipt of treatment and survival in patients with glioblastoma. In: Journal of Neuro-Oncology. 2017 ; Vol. 135, No. 3. pp. 529-534.
@article{788fe62a17004d9ba8791d342a1fddf9,
title = "Association between hospital volume and receipt of treatment and survival in patients with glioblastoma",
abstract = "The relation between hospital volume and outcomes for patients with glioblastoma is unknown. We undertook this study to determine the effect of hospital volume on treatment received and its effect on survival in patients with glioblastoma. We included patients from the National Cancer Database diagnosed with a glioblastoma from 2006 to 2013. Hospital volume was calculated by examining the treating facilities average number of cases per year and grouping them into tertiles: (low < 9.25, medium 9.26–23.88, and high ≥ 23.39). Treatment was defined as receiving any type of therapeutic surgery, radiation or chemotherapy. Using regression models we examined the relation between hospital volume to treatment received and survival with adjustment for clinical, socioeconomic and institutional factors. The study included 68,726 patients of which 91.8{\%} received treatment. Among patients diagnosed at low volume facilities, 90.1{\%} received treatment versus 94.2{\%} in high volume facilities (p < 0.0001). Compared to low volume centers, the odds ratio of receiving any treatment was 1.01 (CI 95{\%} CI: 0.95–1.09) and 1.43 (95{\%} CI: 1.31–1.55) for medium volume and high volume facilities, respectively. On multivariate analysis for survival among those who received treatment, the hazard of mortality was decreased at high volume (HR 0.92, 95{\%} CI 0.89–0.94) facilities compared to low volume facilities. Patients diagnosed with glioblastoma at a high volume facility (≥23.39 cases per year) have an increased likelihood of receiving treatment. Furthermore, glioblastoma patients may significantly improve their survival by choosing to receive care at a high-volume hospital.",
keywords = "Brain tumors, Glioblastoma, Hospital volume",
author = "Matthew Koshy and Sher, {David J.} and Michael Spiotto and Zain Husain and Herb Engelhard and Konstantin Slavin and Nicholas, {Martin K.} and Weichselbaum, {Ralph R.} and Chad Rusthoven",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s11060-017-2598-2",
language = "English (US)",
volume = "135",
pages = "529--534",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Association between hospital volume and receipt of treatment and survival in patients with glioblastoma

AU - Koshy, Matthew

AU - Sher, David J.

AU - Spiotto, Michael

AU - Husain, Zain

AU - Engelhard, Herb

AU - Slavin, Konstantin

AU - Nicholas, Martin K.

AU - Weichselbaum, Ralph R.

AU - Rusthoven, Chad

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The relation between hospital volume and outcomes for patients with glioblastoma is unknown. We undertook this study to determine the effect of hospital volume on treatment received and its effect on survival in patients with glioblastoma. We included patients from the National Cancer Database diagnosed with a glioblastoma from 2006 to 2013. Hospital volume was calculated by examining the treating facilities average number of cases per year and grouping them into tertiles: (low < 9.25, medium 9.26–23.88, and high ≥ 23.39). Treatment was defined as receiving any type of therapeutic surgery, radiation or chemotherapy. Using regression models we examined the relation between hospital volume to treatment received and survival with adjustment for clinical, socioeconomic and institutional factors. The study included 68,726 patients of which 91.8% received treatment. Among patients diagnosed at low volume facilities, 90.1% received treatment versus 94.2% in high volume facilities (p < 0.0001). Compared to low volume centers, the odds ratio of receiving any treatment was 1.01 (CI 95% CI: 0.95–1.09) and 1.43 (95% CI: 1.31–1.55) for medium volume and high volume facilities, respectively. On multivariate analysis for survival among those who received treatment, the hazard of mortality was decreased at high volume (HR 0.92, 95% CI 0.89–0.94) facilities compared to low volume facilities. Patients diagnosed with glioblastoma at a high volume facility (≥23.39 cases per year) have an increased likelihood of receiving treatment. Furthermore, glioblastoma patients may significantly improve their survival by choosing to receive care at a high-volume hospital.

AB - The relation between hospital volume and outcomes for patients with glioblastoma is unknown. We undertook this study to determine the effect of hospital volume on treatment received and its effect on survival in patients with glioblastoma. We included patients from the National Cancer Database diagnosed with a glioblastoma from 2006 to 2013. Hospital volume was calculated by examining the treating facilities average number of cases per year and grouping them into tertiles: (low < 9.25, medium 9.26–23.88, and high ≥ 23.39). Treatment was defined as receiving any type of therapeutic surgery, radiation or chemotherapy. Using regression models we examined the relation between hospital volume to treatment received and survival with adjustment for clinical, socioeconomic and institutional factors. The study included 68,726 patients of which 91.8% received treatment. Among patients diagnosed at low volume facilities, 90.1% received treatment versus 94.2% in high volume facilities (p < 0.0001). Compared to low volume centers, the odds ratio of receiving any treatment was 1.01 (CI 95% CI: 0.95–1.09) and 1.43 (95% CI: 1.31–1.55) for medium volume and high volume facilities, respectively. On multivariate analysis for survival among those who received treatment, the hazard of mortality was decreased at high volume (HR 0.92, 95% CI 0.89–0.94) facilities compared to low volume facilities. Patients diagnosed with glioblastoma at a high volume facility (≥23.39 cases per year) have an increased likelihood of receiving treatment. Furthermore, glioblastoma patients may significantly improve their survival by choosing to receive care at a high-volume hospital.

KW - Brain tumors

KW - Glioblastoma

KW - Hospital volume

UR - http://www.scopus.com/inward/record.url?scp=85027970278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027970278&partnerID=8YFLogxK

U2 - 10.1007/s11060-017-2598-2

DO - 10.1007/s11060-017-2598-2

M3 - Article

C2 - 28836140

AN - SCOPUS:85027970278

VL - 135

SP - 529

EP - 534

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -